Year 1 (n = 2,157) | Year 2 (n = 1,881) | Year 3 (n = 2,029) | Year 4 (n = 1,543) | |||||
---|---|---|---|---|---|---|---|---|
Antibacterial | MIC90 (μg/mL) | Susceptibility (%) | MIC90 (μg/mL) | Susceptibility (%) | MIC90 (μg/mL) | Susceptibility (%) | MIC90 (μg/mL) | Susceptibility (%) |
Penicillin | 4 | 12.3 | 4 | 13.0 | 4 | 14.3 | 4 | 19.0 |
Amoxicillin-clavulanate | ≥ 8 | 71.8 | 4 | 78.8 | 4 | 82.9 | 2 | 90.7 |
Cefuroxime | 8 | 23.4 | 8 | 28.8 | 8 | 34.4 | 8 | 44.5 |
Trimethroprim-sulfamethaxazole | ≥ 8 | 12.4 | ≥ 8 | 17.1 | ≥ 8 | 19.0 | ≥ 8 | 27.6 |
Tetracycline | ≥ 8 | 71.7 | ≥ 8 | 71.4 | ≥ 8 | 76.5 | ≥ 8 | 81.2 |
Erythromycin | 16 | 0 | 16 | 0 | 16 | 0 | 16 | 0 |
Azithromycin | 32 | 0 | 32 | 0.2 | 16 | 0 | 32 | 0 |
Clarithromycin | 16 | 0.1 | 8 | 0.4 | 8 | 0.1 | 16 | 0.1 |
Levofloxacin | 1 | 99.0 | 1 | 97.7 | 1 | 98.6 | 1 | 98.6 |
Telithromycin | 1 | 99.1 | 0.5 | 99.9 | 0.5 | 99.9 | 0.5 | 99.9 |